Living kidney donor and recipient evaluation in fabry's disease

Transplantation

Volumn 54, Issue 5, 1992, Pages 924-927

  Schweitzer, Eugene J ^a   Drachenberg, Cinthia B ^a   Bartlett, Stephen T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GALACTOSIDASE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; COLON PERFORATION; CORNEA OPACITY; FABRY DISEASE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; SURGICAL RISK; X CHROMOSOME RECESSIVE INHERITANCE;

CASE REPORT; EVALUATION STUDIES; FABRY DISEASE; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; PEDIGREE; TISSUE DONORS;

EID: 0026499232     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199211000-00030     Document Type: Note

References (30)

1. Percy AK. Gangliosidoses and related lipid storage diseases. In: Emery AEH, Rimoin DL, eds. Principles and practice of medical genetics. New York: Churchill Livingstone, 1990: 1827.
2. Desnick RJ, Sweeley CC. Fabry's disease: a-galactosidase A deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1983: 906.
3. Nyhan WL, Sakati NA. Diagnostic recognition of genetic disease. Philadelphia: Lea & Febiger, 1987: 352.
4. Advisory Committee to the Renal Transplant Registry. Renal transplantation in congenital and metabolic diseases. JAMA 1975; 232: 148.
5. Maizel SE, Simmons RL, Kjellstrand C, Fryd DS. Ten-year experience in renal transplantation for Fabry's disease. Transplant Proc 1981; 13: 57.
6. Donati D, Novario R, Gastaldi L. Natural history and treatment of uremia secondary to Fabry's disease: an European experience. Nephron 1987; 46: 353.
7. Mosnier JF, Degott C, Bedrossian J, et al. Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation. Transplantation 1991; 51: 759.
8. Friedlander MM, Kopolovic J, Rubinger D, et al. Renal biopsy in Fabry's disease eight years after successful renal transplantation. Clin Nephrol 1987; 27: 206.
9. Schweitzer EJ, Matas AJ, Gillingham KJ, et al. Causes of renal allograft loss: progress in the 1980s, challenges for the 1990s. Ann Surg 1991; 214: 679.
10. Peters PC, Leeber D, Hull AR, Philippart M. Renal transplantation in Fabry's disease. J Urol 1973; 109: 548.
11. Faraggiana T, Churg J, Grishman E, et al. Light and electron microscopic histochemistry of Fabry's disease. Am J Pathol 1981; 103: 247.
12. Chen HC, Tsai JH, Lai YH, Guh JY. Renal changes in heterozygous Fabry's disease—a family study. Am J Kidney Dis 1990; 15: 180.
13. Gubler MC, Lenoir G, Grunfeld JP, Ulmann A, Droz D, Habib R. Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 1978; 13: 223.
14. Farge D, Nadler S, Wolfe LS, Barre P, Jothy S. Diagnostic value of kidney biopsy in heterozygous Fabry's disease. Arch Pathol Lab Med 1985; 109: 85.
15. DeGroot WP. Angiokeratoma corporis diffusum Fabry. Dermatologica 1964; 128: 321.
16. Franceschetti AT, Philippart M, Franceschetti A. A study of Fabry's disease: clinical examination of a family with cornea verticillata. Dermatologica 1969; 138: 209.
17. Hainaut P, Mugabo P, Schapira M, Coche E. Renal insufficiency manifesting a heterozygote form of Fabry's disease. Acta Clin Belg 1988; 43: 374.
18. Rodriguez FH, Hoffmann EO, Ordinario AT, Baliga M. Fabry's disease in a heterozygous woman. Arch Pathol Lab Med 1985; 109: 89.
19. Kint JA, Carton D. Fabry's disease. In: Hers HG, Van Hoof F, eds. Lysosomes and storage diseases. New York: Academic, 1973:357.
20. Lyon M. Gene action in the X-chromosome of the mouse. Nature 1961; 190: 372.
21. Sher NA, Letson RD, Desnick RJ. Ocular manifestations in Fabry's disease. Arch Ophthalmol 1979; 97: 671.
22. Desnick RJ, Allen KY, Desnick SJ, Raman MK, Bernlohr RW, Krivit W. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes: alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 1973; 81: 157.
23. Kobayashi T, Shinnoh N, Kuroiwa Y. Metabolism of ceramide trihexoside in cultured skin fibroblasts from Fabry's patients, carriers and normal controls. J Neurol Sei 1984; 65: 169.
24. Beaudet AL, Caskey CT. Detection of Fabry's disease heterozygotes by hair root analysis. Clin Genet 1978; 13: 251.
25. O'Brien BD, Shnitka TK, McDougall R, et al. Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry's disease. Gastroenterology 1982; 82: 957.
26. Sheth KJ, Serlin SL, Freeman ME, Hodach AE. Gastrointestinal structure and function in Fabry's disease. Am J Gastro 1981; 76: 246.
27. Rowe JW, Gilliam JI, Warthin TA. Intestinal manifestations of Fabry's disease. Ann Intern Med 1974; 81: 628.
28. Friedman LS, Kirkham SE, Thistlethwaite JR, Platika D, Kolodny EH, Schuffler MD. Jejunal diverticulosis with perforation as a complication of Fabry's disease. Gastroenterology 1984; 86: 558.
29. Carter D, Choi H, Telford G, Otterson M, Chitapalli K, Pintar K. Lymphadenopathy and entero-vesical fistula in Fabry's disease. Am J Clin Pathol 1988; 90: 726.
30. Bryan A, Knauft RF, Burns WA. Small bowel perforation in Fabry's disease. Ann Intern Med 1977; 86: 315.